Key words in there KK2 - With and without diabetes. 

I could see the new owner doing 3 to 5 P3 trials for apabetalone for different indications after a successful BoM2 and the acquisition is completed.

It would be nice if that old adage plays out; Nobody likes you until somebody likes you and then everybody likes you.

Lets get to the first one first.

tada